Key residues in Mycobacterium tuberculosis Protein kinase G play a role in regulating kinase activity and survival in the host by Tiwari, Divya et al.
Key Residues inMycobacterium tuberculosis Protein Kinase G
Play a Role in Regulating Kinase Activity and Survival in
the Host*□S
Received for publication, June 21, 2009 Published, JBC Papers in Press, July 28, 2009, DOI 10.1074/jbc.M109.036095
Divya Tiwari‡1, Rajnish Kumar Singh‡, Kasturi Goswami‡, Sunil Kumar Verma§1, Balaji Prakash§,
and Vinay Kumar Nandicoori‡2
From the ‡National Institute of Immunology, Aruna Asaf Ali Marg, NewDelhi 110067 and the §Department of
Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India
Protein kinase G (PknG) in Mycobacterium tuberculosis has
been shown to modulate phagosome-lysosome fusion. The pro-
tein has three distinct domains, an N-terminal Trx domain, a
kinase domain, and a C-terminal TPR domain. The present
study extensively analyzes the roles of these domains in regulat-
ing PknG kinase activity and function. We find that the kinase
domainofPknGby itself is inactive, signifying the importance of
the flanking domains. Although the deletion of the Trx domain
severely impacts the activity of the protein, the C-terminal
region also contributes significantly in regulating the activity of
the kinase. Apart from this, PknG kinase activity is dependent
on the presence of threonine 309 in the p 1 loop of the activa-
tion segment. Mutating the conserved cysteine residues in the
Trxmotifs makes PknG refractory to changes in the redox envi-
ronment. In vitro experiments identify threonine 63 as the
major phosphorylation site of the protein. Importantly, we find
that this is the only site in the protein that is phosphorylated in
vivo. Macrophage infection studies reveal that the first 73 resi-
dues, theTrxmotifs, and the threonine 63 residue are independ-
ently essential formodulatingPknG-mediated survival ofmyco-
bacteria in its host. We have extended these studies to
investigate the role of PknG andPknGmutants in the pathogen-
esis of mycobacteria in mice. Our results reinforce the findings
from the macrophage infection experiments, and for the first
time demonstrate that the expression of PknG in non-patho-
genicmycobacteria allows the continued existence of these bac-
teria in host tissues.
Protein kinases are a diverse class of proteins that have been
shown to play a critical role in regulating cellular processes by
transmitting extracellular cues/intracellular signals to their
downstream substrates by phosphorylation of serine, threo-
nine, or tyrosine residues on the substrates. The Mycobacte-
rium tuberculosis genome encodes for 11 eukaryotic-like ser-
ine/threonine protein kinases (1). PknG is likely to be the only
soluble kinase as all other kinases either have a putative trans-
membrane domain or are shown to be localized to the mem-
brane fraction (2, 3). Other than PknJ, the other kinases have
been biochemically characterized, and downstream target sub-
strates of nine kinases have been identified (3–19). Many of
these kinases are reported to be involved in key regulatory func-
tions (20–24). In addition, there exists a possibility that these
kinasesmay be involved in cross-talk with host kinases. Various
studies have shown that two of these kinases, PknA and PknB,
are essential for growth, and are involved in regulating cell
shape (4, 25). PknF, PknH, PknD, and PknK regulate gene
expression levels by phosphorylating transcription factors (3,
21, 26–28). Crystal structures of the kinase domains of PknB,
PknE, and PknG as well as the sensor domain of PknD, have
been determined, and all of them exhibit the typical two lobed
organization observed in eukaryotic serine/threonine kinases.
The N-terminal lobe contains the ATP binding site, whereas
the C-terminal lobe is involved in rendering an active state and
in stabilizing interactions with the substrate (29–34).
Protein kinaseG (PknG)3 is closely related to themammalian
protein kinase C. Unlike most M. tuberculosis serine/threo-
nine protein kinases (STPKs), it does not have a transmem-
brane domain and has been shown to be localized to the bacte-
rial cytosol and membrane (35). This 82-kDa protein has a Trx
domain at theN terminus, a central kinase domain, and aC-ter-
minal TPR motif. It has been shown to autophosphorylate the
kinase and the C-terminal TPR domains (35). The gene encod-
ing PknG is located in an operon with glnH.The inactivation of
pknG inM. tuberculosis results in a 3-fold higher accumulation
of glutamate and glutamine as well as reduced expression of
glutamine synthetase (35). However, another report suggests
that the deletion of pknG inMycobacteriumbovisBCGdoes not
affect glutamine uptake or intracellular glutamine concentra-
tion (36). Walburger et al. (37) analyzed the intracellular traf-
ficking of pknG-deficient M. bovis BCG after macrophage
infection. Their data revealed rapid lysosomal transfer of
phagocytosed (mutant) mycobacteria. The ortholog of PknG in
Mycobacterium smegmatis, a non-pathogenic soil bacterium, is
not expressed due to an altered ribosome binding site (8, 23).
Upon infecting macrophages, wild typeM. smegmatis is trans-
* This work was supported by the Department of Biotechnology (DBT), India
(to V. K. N. and B. P.) and by an International Research Fellowship grant
from the Wellcome Trust, United Kingdom (to B. P.).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1–S2 and Table S1.
1 Senior Research Fellows of the Council of Scientific and Industrial Research,
India.
2 To whom correspondence should be addressed. Tel.: 91-11-26703789; Fax:
91-11-26742125; E-mail: vinaykn@nii.res.in.
3 The abbreviations used are: PknG, protein kinase G; STPK, serine/threonine
protein kinase; MBP, maltose-binding protein; DTT, dithiothreitol; Mbp,
myelin basic protein; HPLC, high pressure liquid chromatography; GFP,
green fluorescent protein; CFU, colony forming unit.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 284, NO. 40, pp. 27467–27479, October 2, 2009
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
OCTOBER 2, 2009•VOLUME 284•NUMBER 40 JOURNAL OF BIOLOGICAL CHEMISTRY 27467
 by guest on M
arch 30, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ferred to lysosomal compartments, whereasM. smegmatis car-
rying overexpressed PknG is largely present in the non-lysoso-
mal fraction of the cell (37). These results suggest a role for
PknG in modulating lysosomal transfer of mycobacteria. PknG
kinase activity has been shown to be essential for preventing
lysosomal transfer of the phagocytosed mycobacteria. PknG
was also shown to be secreted into the cytosol of host macro-
phages during M. bovis BCG infection (37). Although there is
no identifiable N-terminal signal sequence for secretion in
PknG, it is known that mycobacterium species have alternate
secretory pathways that may aid in secretion of such molecules
(38, 39). Although the essential role of an active formof PknG in
M. tuberculosis infection has been established, there are no
reports to date regarding the exact mechanism involved. M.
tuberculosis PknG shares about 45% identity and 59% homol-
ogy with corynebacterial PknG (CgPknG), its ortholog in
Corynebacterium glutamicum. CgPknG is not autophosphoryl-
ated, but rather, is transphosphorylated by another kinase,
CgPknA. This transphosphorylation at the C-terminal domain
is essential for the activity of the protein and also the phospho-
rylation of its downstream substrate (40).However, inM. tuber-
culosis, PknG has been reported to be autophosphorylated in
vitro, signifying mechanistic differences in the regulation of
PknG and CgPknG.
In this study, we have focused on deciphering the regulatory
roles of the various domains ofM. tuberculosis PknG.We have
utilized GarA as the substrate in in vitro kinase assays, and used
GarA phosphorylation as readout of PknG activity. Results of
experiments with various deletion mutants of PknG show that
although the N-terminal region of PknG is crucial, deleting the
C-terminal region also results in loss of activity. In addition, we
demonstrate that PknG is more active in an oxidizing environ-
ment rather than in a reducing environment and that Trx
motifs play a role in sensing the redox environment. A major
finding of this investigation is that threonine 63 (Thr-63) is a
key phosphorylation site in the N-terminal domain, and is the
only site phosphorylated in vivo. Macrophage infection exper-
iments show that the N-terminal region of PknG, including the
in vivo phosphorylation site Thr-63 and the Trx motifs are
essential for PknG-mediated evasion of lysosomal transfer of
mycobacteria in hostmacrophages. Results frommice infection
studies with M. smegmatis expressing PknG or PknG mutants
conclusively demonstrate a role for PknG in the persistence of
pathogenic mycobacteria in its host. Most importantly, dele-
tion of the N-terminal 73 residues, or mutating the Trx motifs,
results in the abrogation of PknG-mediated survival of myco-
bacteria in host tissues.
EXPERIMENTAL PROCEDURES
Reagents and Radioisotopes—Restriction/modification en-
zymes were obtained from New England Biolabs. Cloning and
expression vectors pQE2 (Qiagen) and pMAL-c2X (New Eng-
land Biolabs) were purchased from the respective sources.
pVV16 (an Escherichia coli-Mycobacterium shuttle vector) was
kindly provided by TB Vaccine Testing and Research Material
Contract. [-32P]ATP (6000 Ci/mmol) was purchased from
PerkinElmer Life Sciences. Inorganic [32P]orthophosphate
(H332PO4) was obtained from the Board of Radiation and Iso-
tope Technology, Hyderabad, India. Oligonucleotide primers
and analytical grade chemicals were purchased from Sigma.
Sequencing of DNA was performed by MWG (India).
Protein Expression and Purification—Sequences of all the
primers used and the details of all the plasmid constructs used
in this study are given under supplemental Materials. Both
pMAL-c2X- and pQE2-based constructs were transformed in
DH5 competent cells for protein expression. Fresh transfor-
mants were grown in 500–1000 ml of LB medium containing
100 g/ml ampicillin to a cell density of A600 of0.6. Purifica-
tion of PknGwas carried out as described earlier (37). For GarA
purification, cultures were inducedwith 1mM isopropyl 1-thio-
-D-galactopyranoside, followed by incubation at 37 °C for 5 h.
His-tagged proteins were purified as described (37). Fractions
were analyzed on SDS-PAGE and those containing PknG/GarA
were pooled and dialyzed against a Tris-based buffer (10 mM
Tris-HCl, pH 7.5, 20 mM NaCl, and 20% glycerol). Maltose-
binding protein-tagged (MBP) proteins were purified following
the manufacturer’s recommendations (New England Biolabs).
All the purified proteins were estimated and stored at 70 °C
until further use.
In Vitro Kinase Assay, Phosphopeptide Maps, and Phos-
phoamino Acid Analysis—In vitro kinase assays were per-
formed in a 40-l reaction containing 25 mM HEPES-NaOH,
pH 7.4, 20 mM magnesium acetate, 20 M MnCl2, 1 mM DTT,
200 M sodium orthovanadate, 100 M cold ATP, 10 Ci of
[-32P]ATP, and 5 pmol of GarA or other substrates such as
myelin basic protein (Mbp), with or without 1 pmol of PknG or
its fragments, for 10 min at 30 °C. The reactions were stopped
by adding 15l of 4 SDS sample buffer followed by heating at
95 °C for 5 min. Reactions were resolved on 12% SDS-PAGE
gels, and either transferred to nitrocellulose membrane or
stained with Coomassie/silver and exposed to x-ray films for
autoradiography. For quantitation, the desired bands were cut
from the gels, soaked in scintillationmixtureW (Spectrochem),
and counts were taken using a liquid scintillation counter
(Packard analyzer Tri-carb 2100 TR). Kinase assays in oxidized
versus reduced environments were carried out as described
above in the presence of 1 mM oxidized or reduced DTT,
respectively. For these experiments, PknG and itsmutants were
purified in the absence of DTT or -mercaptoethanol.
To determine the kinetic constants, reactions were carried
out in a 40-l volume, in 25 mMHEPES-NaOH, pH 7.4, 20 mM
magnesium acetate, and 1 mM DTT, containing 50 M cold
ATP, 10 Ci of [-32P]ATP, and 50, 125, or 250 nM PknG,
PknG-(1–420), or PknG-(74–750), respectively, for 20 min at
30 °C.Concentrations ofGarA in the reaction varied from0.125
to 5 M. The concentration (nM) of phosphorylated GarA was
determined using the counts per nanomolar ATP. The rate of
the phosphotransfer reaction was defined as nanomolar GarA
phosphorylated/min/micromolar enzyme. Km and Vmax values
were determined by non-linear regression analyses carried out
with GraphPad prism software.
For two-dimensional phosphopeptide maps or phos-
phoamino acid analysis, bands corresponding to the pro-
tein(s) of interest were excised from the nitrocellulose mem-
brane and digested with mass spectrometry grade trypsin
gold (Promega). The peptides were analyzed by two-dimen-
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sional resolution on thin-layer cellulose plates (41). Aliquots
of the tryptic peptide mixtures were further processed and
phosphoamino acid analysis was carried out as described
(41).
Reverse Phase-HPLC—Reverse phase-HPLC was performed
using a C-18 column (PerkinElmer Life Sciences). 20 g of
Radiolabeled PknG was subjected to trypsin digestion and
mixed with 200 g of trypsin-digested PknG. This mixture was
resolved by HPLC (PerkinElmer Life Sciences) using a 20–80%
acetonitrile gradient. The peaks were monitored with UV as
well as the radioactive detector and the peaks that were
detected with the radioactive detector were collected. Two-di-
mensional peptide maps of these collected radioactive peaks
were performed as described (41).
In Vivo Labeling of M. smegmatis—M. smegmatis harboring
pVV16-PknG, pVV16-PknG-K181M, or pVV16-PknG-T63A
were grown in 200 ml of Middlebrook 7H9 medium (Difco)
supplemented with albumin, dextrose, and catalase and 25
g/ml kanamycin until an O.D. of 1.5 was reached. Cells were
harvested by centrifugation at 3,000  g for 10 min at room
temperature and washed once with phosphate-free 7H9medium,
followed by phosphate starvation in 200 ml of 7H9 phosphate-
free medium for 6 h. Cells were har-
vested as described, and resus-
pended in 50 ml of phosphate-free
medium containing phosphatase
inhibitors (sodium orthovanadate,
-glycerophosphate, sodium fluo-
ride, and sodium pyrophosphate)
and 20 mCi of [32P]orthophospho-
ric acid and incubated at 37 °C for
8 h at 100 g. Cells were harvested
and lysed using a bead beater in lysis
buffer containing phosphate-buff-
ered saline and protease inhibitors.
The cell lysates were clarified by
centrifugation at 15,000  g for 60
min, and the supernatant was incu-
bated with nickel-agarose beads
overnight at 4 °C. The beads were
then thoroughly washed with lysis
buffer containing 5 mM imidazole,
and resuspended in SDS sample
buffer. The samples were resolved
on 10% SDS-PAGE, transferred to
nitrocellulose membrane, and the
radiolabeled bands were visualized
by phosphorimaging.
Macrophage Infection Experi-
ments—M. smegmatis expressing
green fluorescent protein (GFP) was
transformed with pVV16 vector,
PknG, or PknG mutants. Infection
experiments were carried out as
described (37) except that lyso-
tracker red was used to detect lyso-
somes. Briefly, J774A.1 cells (5 
105) were plated on coverslips and
infected at a multiplicity of infection of 1:10 for 1 h, followed by
a 3-h chase. Coverslips were removed at the given time points
and stained with 0.5 M lysotracker red diluted in Dulbecco’s
modified Eagle’s medium for 10 min in the dark at 37 °C fol-
lowed by 3 washes with phosphate-buffered saline and fixation
with 4% paraformaldehyde. Coverslips were thenmounted and
visualized using either a Carl Zeiss Imager M1 fluorescence
microscope or a Carl Zeiss Axiovision LSM510 meta confocal
microscope.
In Vivo Infection with Recombinant M. smegmatis—
C57BL/6J mice were obtained from The Jackson Laboratories
and maintained in pathogen-free autoclaved cages in isolators.
Three mice per group were injected with 2 107 colony form-
ing units (CFU) of M. smegmatis (in 0.9% NaCl) transformed
with pVV16 vector, PknG, or PknGmutants by intraperitoneal
injection. The final inocula were diluted and plated to confirm
the actual bacterial input. The survival of recombinant myco-
bacteria in mouse organs were determined at 2, 5, and 10 days
post-infection as described (42, 43). Briefly, the mice were sac-
rificed and the liver, lung, and spleen were removed aseptically,
and homogenized using a Down’s homogenizer. The tissue
homogenates were serially diluted and aliquots from each dilu-
FIGURE 1. GarA is an in vitro substrate of PknG. A, E. coli DH5 cells were transformed with pQE2-PknG, and
His-tagged PknGwas purified as described under “Experimental Procedures.” Lane 1, uninduced lysate; lane 2,
induced lysate (0.1mM isopropyl 1-thio--D-galactopyranoside); lane 3, induced lysate (1mM isopropyl 1-thio-
-D-galactopyranoside); and lane 4, affinity purified His-PknG. B, in vitro kinase assays were carried out using 1
pmol of PknG with or without 5 pmol of GarA as described. These reactions were resolved on 12% SDS-PAGE,
silver stained, and exposed for autoradiography. Left panel, silver-stained gel; right panel, corresponding auto-
radiogram. Bands corresponding to PknG and GarA are indicated by arrows. C, in vitro kinase reactions were
carried outwith 1 pmol of PknG and 5 pmol of canonical substrates or GarA as indicated. Bands corresponding
to Mbp, histone HIIA, and GarA are indicated. D, phosphoamino acid analysis of radiolabeled PknG. p-,
phosphorylated.
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tion were plated in triplicate onMiddlebrook 7H10 agar plates.
Total CFUs obtained were normalized with respect to the bac-
terial input.
RESULTS
GarA Is an in Vitro Substrate of PknG—A comparative anal-
ysis of the proteomes ofwild type and the pknGdeletionmutant
of C. glutamicum led to the identification of OdhI as a likely
substrate of CgPknG (44). OdhI is homologous to themycobac-
terial protein GarA, a protein known to be secreted in a trun-
cated form intoM. tuberculosis culture filtrate (CFP-17), and to
induce a high interferon- response in inbred mice (45). This
protein has earlier been identified as a substrate ofM. tubercu-
losis PknB, and the PknB-mediated phosphorylation sites have
been determined (46). As CgPknG and M. tuberculosis PknG
(PknG) share a high degree of homology, we investigated the
possibility of GarA being a substrate of PknG. Accordingly, the
gene encoding PknG was amplified from a BAC library and
cloned into pQE2 vector, and the overexpressed protein was
purified to near homogeneity (Fig. 1A). Similarly, the gene
encoding GarA (Rv1827) was cloned into pQE2, and overex-
pressedGarAwas purified to homogeneity (data not shown). In
vitro kinase assays carried out with the purified PknG using
GarA as test substrate demonstrated that GarA is a substrate of
PknG (Fig. 1B). In an earlier report, PknG was shown to phos-
phorylateMbp, the universal kinase substrate (8). Interestingly,
when we compared the ability of PknG to phosphorylate GarA
and various canonical kinase substrates, only a weak phospho-
rylation of histone HIIA and Mbp was detected in comparison
to the phosphorylation seen with GarA. As apparent from Fig.
1C, GarA is the optimal substrate among the four that were
tested, and hence GarA was used as the substrate to assess
PknG kinase activity in further experiments. Phosphoamino
acid analysis of phosphorylated PknG showed that phosphoryl-
ation was exclusively on threonine residues (Fig. 1D).
TheN-terminal Region of PknGModulates Its Kinase Activity—
Among the 11 kinases annotated in theM. tuberculosis genome,
PknG is unique due to the presence of an N-terminal extension
preceding the kinase domain. In the remaining STPKs, the
kinase domain is located in the N terminus followed by regions
that, in some of the kinases, regulate their activity (2, 47, 48).
The kinase domain of PknG is located between amino acid res-
idues 151 and 396. The 150-amino acid N-terminal region that
precedes it harbors the conserved Trx motifs. The kinase
domain is followed by a 354-amino acid C-terminal region
showing homology to a TPR domain. To investigate the roles of
these flanking regions in modulating PknG kinase activity, we
created various deletion mutants of PknG (Fig. 2A). Analysis of
proteins on SDS-PAGE showed that all are purified to near
homogeneity and are stable (Fig. 2B). The kinase domain by
itself (MBP-PknG-(151–410)) did not show any activity, sug-
gesting the requirement of either N- or C-terminal domains or
both for PknG activity (data not shown). The PknG fragment
lacking the C-terminal TPR domain (PknG-(1–420)) showed
significantly decreased kinase activity (Fig. 2,C andD,50% of
wild type activity). Deleting the N-terminal 150 amino acids
(PknG-(151–750)), however, resulted in the activity of PknG
being critically compromised to less than 5% of the activity
shown by wild type (Fig. 2, C andD). About 25% kinase activity
was restored when amino acids 74–150 were reintroduced
(PknG-(74–750)) (Fig. 2, C and D). Interestingly, a PknG frag-
ment that lacks both the first 73 amino acids and theC-terminal
421–750 amino acid region (PknG-(74–420)) shows only mar-
ginal activity comparedwith the full-length protein. The kinetic
parameters for PknG, PknG-(1–420), and PknG-(74–750)
were determined. We were unable to determine the kinetic
parameters for PknG-(151–750) and PknG-(74–420), as their
activity was severely compromised. Results indicate (Table 1)
that deletion of either the N-terminal 74 amino acids or the
C-terminal region results in decreased Vmax and increased Km
values. Although, the decrease in Vmax was similar in both C-
and N-terminal deletion mutants, the Km seems to be more
significantly altered in the case of PknG-(74–750), suggesting
an important role for theN-terminal region inmodulating sub-
strate binding affinity. Taken together, our results indicate that
although the N-terminal (first 150 amino acids) is absolutely
essential for PknG kinase activity, the C-terminal region also
plays a significant role in regulating its activity.
TheTrxMotifs in theN-terminal Region of PknGAre Involved
in Redox Sensing—Results in Fig. 2 clearly demonstrated that
amino acids 74–150 are important in regulating PknG kinase
activity and hence we set out to investigate the role played by
this region. This region harbors two Trx-fold motifs
106CXXC109 and 128CXXC131. Trx motifs are frequently found
in thioreductases and are involved in sensing the changes in the
redox potential in the microenvironment such that the activity
of the proteins aremodified accordingly.We hypothesized that
these residues may play a similar role in PknG. Because each of
the motifs contain two cysteine residues in the signature
sequence, we made two double mutants, PknG-T1 (C106A,
C109A) and PknG-T2 (C128A, C131A), by mutating the cys-
FIGURE 2. The N-terminal region of PknGmodulates its kinase activity. A, schematic representation of PknG and PknG deletion mutants. B, purified PknG
and PknG mutants were resolved on 10% SDS-PAGE and stained with Coomassie. C, comparison of kinase activities of PknG and PknG deletion mutants. Left
panel, in vitro kinase assays carried out using 1 pmol of His-PknG or His-tagged PknGmutants in a 40-l reaction with or without 5 pmol of GarA. Right panel,
in vitro kinase assays carried out using 1 pmol of MBP-PknG or MBP-tagged mutants with or without 5 pmol of GarA. D, the relative activity of various His- or
MBP-tagged PknGmutants were calculatedwith respect to GarA phosphorylation by His or MBP-PknG (that were set to 100%), respectively. Relative values of
substrate phosphorylation with PknGmutants in three independent experiments were used to calculate the S.D. (error bars).
TABLE 1
The kinetic constants for PknG and PknG deletion mutants
Values obtained from three independent experiments were used for calculating the
mean  S.E. Kinetic constants for PknG-(74–420) and PknG-(151–750) were not
determined as the activity was significantly compromised. Relative Vmax/Km values
were calculated relative to the values obtained for reference protein PknG.
Protein Km Vmax Vmax/Km RelativeVmax/Km
nM nM phosphate
transferred/min/M
enzyme
PknG 2122 126 102.4 15.56 48 100
PknG-(1–420) 3475 588 33.2 6.33 9.6 20
PknG-(74–750) 6509 485 22.8 2.64 3.6 7.5
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teine residues to alanine. In addition we created a combination
mutant where we simultaneously mutated all four cysteine res-
idues to alanine (PknG-T1T2). In vitro kinase assays using
GarA as the substrate revealed that mutating either Trx
domains separately decreases PknG activity by 30%. How-
ever, the combination mutant, PknG-T1T2, showed25–50%
activity compared with the wild type protein (Fig. 3A and data
not shown). To examine the possibility of these motifs modu-
lating the activity of the protein by sensing changes in the redox
potential of the environment, kinase assays were performed
using wild type PknG and the Trx mutant (PknG-T1T2) in the
presence of 1 mM reduced DTT or oxidized DTT. Wild type
PknG showed a 2.5-fold higher activity in the oxidized envi-
ronment as compared with the reduced environment (Fig. 3B).
As expected, PknG-T1T2 showed decreased activity compared
with PknG. Interestingly, we could only detect a marginal dif-
ference (5%), if any, in the activity of this mutant in the oxi-
dized and reduced environments. Fortuitously, both Trx
motifs in PknG are flanked by tryptophan residues, which
enabled us to utilize intrinsic tryptophan fluorescence spec-
troscopy to monitor structural changes between wild type
and mutant proteins. Our results indicate that mutant
PknG-T1T2 displayed a 2-fold increase in fluorescence as
compared with wild type, suggesting significant structural
changes (Fig. 3C) in the protein. These data underline the
importance of Trx motifs and the cysteine residues therein,
in maintaining internal disulfide bonds. Taken together, it
appears that PknG activity is modulated by the redox state of
the surrounding microenvironment and the cysteine resi-
dues are critical for this phenomenon.
A Threonine Residue in the p  1 Loop Is Crucial for PknG
Activity—Kinases are known to be activated by the phosphoryl-
ation of one or more serine, threonine, or tyrosine residues in
their activation loop. The activation loop comprises the region
that includes the 9 helix of the kinase domain and is sand-
wiched between conserved DFG and APE motifs (Fig. 4A).
Although this region is known to be variable, these residues
seem to be conserved between PknB, -D, -E, and -F (Fig. 4A).
Activation loop residues that are phosphorylated have been
identified in PknB, -D, -E, and -F (indicated by an asterisk in Fig.
4A) (49). Interestingly, in the case of PknG, sequence alignment
shows no conserved threonine residues in the activation loop.
However, a threonine (Thr-309) is present in the p  1 loop
(Fig. 4A). The activation loop is followed by a p 1 loop, which
is important for kinase-substrate interactions. A threonine res-
idue in this region is also reported to be phosphorylated in PknE
(49).Wedetermined the role of the threonine residue in the p
1 loop of PknG. It can be seen from Fig. 4B that mutating this
threonine to alanine (PknG-T309A) resulted in complete loss
of PknG activity. A comparison of CD spectra obtained with
PknG and PknG-T309A showed no significant difference (sup-
plemental Fig. S1), thus precluding any gross structural
changes. The loss of kinase activity of the PknG-T309Amutant
could be either because the phosphorylation of this residue is
essential to the activity of the protein, or alternatively, due to
loss of interactions mediated through the hydroxyl group on
the threonine residue. To distinguish between these two
possibilities, we made mutants of PknG where Thr-309 was
replaced with either a phosphomimic amino acid such as
glutamate or aspartate, or with a serine residue that can pro-
vide a hydroxyl group. If the phosphorylation of Thr-309
FIGURE 3. The Trx motifs in the N-terminal region of PknG are involved in
redox sensing. A, in vitro kinase assays were carried out with PknG or PknG-T1
(106CXXC109 224 106AXXA109) or PknG-T2 (128CXXC131 224 128AXXA131) or PknG-
T1T2 (simultaneousmutationofall fourcysteineresidues)withorwithout5pmol
ofGarA.B, in vitro kinase assayswere carriedoutwithPknGorPknG-T1T2using5
pmol of GarA as the substrate in the presence of 1mM oxidized DTT or reduced
DTT. Percent activity was calculatedwith respect to phosphorylation of GarA by
PknG in thepresenceof1mMoxidizedDTT.Relativevaluesof the percent phos-
phorylation from three independent experiments were used for calculat-
ing the standard deviation (error bars). C, tryptophan fluorescence spectra of PknG
(solid line) and thePknG-T1T2mutant (dotted line). Fluorescencewasmeasuredafter
excitationat280nmandemissionwas readat280–420nm.
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were to play a role in modulating PknG activity, T309E or
T309D should be able to rescue the loss of activity of T309A.
However, if the hydroxyl group of threonine plays a role,
T309S should be able to restore partial activity. Our results
show that both PknG T309E and T309D mutants are inac-
tive, whereas the T309S mutant shows partial restoration of
FIGURE 4.A threonine residue in the p 1 loop is crucial for PknG activity. A, sequence alignment of the activation loop segment region of PknGwith that
of PknB, PknD, PknE, and PknF. Regions corresponding to the 9 helix, activation loop, and p 1 loop are marked. Activation loop residues demonstrated to
be phosphorylated in PknB, PknD, PknE, and PknF (49) are marked with an asterisk. B, in vitro kinase assays carried out with 1 pmol of PknG, PknG-K181M, and
PknG-T309A in a 40-l reaction with or without 5 pmol of GarA. Reactions were resolved on 12% SDS-PAGE, silver stained, and the gel was exposed for
autoradiography. Left panel, silver-stained gel; right panel, corresponding autoradiogram. Bands corresponding to PknG and GarA are indicated. C, in vitro
kinase assays carried out with PknG and PknG mutants using GarA as the substrate. Reactions were resolved on 12% SDS-PAGE and the gel was stained and
subjected to autoradiography. Bands corresponding to PknG and GarA are indicated.
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activity compared with the wild type (Fig. 4C). These data
implicate a role for threonine 309 in either structural stabi-
lization of the activation loop region or in arbitrating kinase-
substrate interaction.
PknG Exhibits Trans-phosphorylation—In agreement with
previous reports (8, 35), a strong phosphorylation of PknG was
detected in vitro kinase assays (Fig. 1, B and C). To examine if
the observed phosphorylation of PknG occurs in vivo, we over-
expressedM. tuberculosis PknGwith a C-terminal His tag inM.
smegmatis and carried outmetabolic labeling experiments with
[32P]orthophosphoric acid. Our results clearly show (Fig. 5A)
that PknG is indeed phosphorylated in vivo. Phosphorylation of
PknGcould be either due to autophosphorylation or transphos-
phorylation, i.e. phosphorylation of one kinase molecule by
another. To address this, we created His-tagged PknG-K181M,
a mutant that lacks any kinase activity. The conserved lysine
(Lys-181) present in the Walker A motif is known to stabilize
ATP via interactionswith and phosphates. Results of exper-
iments presented in Fig. 4B confirm that the His-PknG-K181M
mutant is indeed inactive. To discriminate between intramo-
lecular phosphorylation versus intermolecular phosphorylation
(trans-phosphorylation), we carried out in vitro kinase assays
with wild type maltose-binding protein-tagged PknG (MBP-
PknG) and His-tagged PknG-K181M mutant. The fact that we
noticed a distinct phosphorylation of His-PknG-K181M, when
MBP-PknG was included in the reactions (Fig. 5B) demon-
strates that PknG phosphorylation occurs in trans. Although
this transphosphorylation is being brought about by intermo-
lecular interactions between PknGmolecules in vitro, in vivo it
may also occur due to phosphorylation by other kinases.
Threonine 63 Is a Major Phosphorylation Site in PknG—To
identify the residues that are phosphorylated in PknG, we
employed reverse phase-HPLC attached to a radioactive detec-
tor. Phosphorylated PknG was subjected to tryptic digestion
and the resulting radiolabeled tryptic fragments were resolved
on a C-18 reverse phase-HPLC column. Five distinct radioac-
tive peaks were detected, of which peaks 1 and 5 are the major
peaks (Fig. 6A). A comparison of the peptide maps of the wild
type protein (PknG in Fig. 6B) with those for peaks 1–5 clearly
indicated that all major spots with the exception of spot 6 of the
wild type peptide map were accounted for in peptide maps of
peaks 1–5 (Fig. 6B). Among the two prominent peaks, peak 1
corresponds to two major spots and peak 5 corresponds to
three. As our experiments revealed that the N-terminal region
is important in modulating PknG activity, we investigated pos-
sible phosphorylation of this region. To address this, we cloned
and expressed the N-terminal 150 amino acids of PknG (PknG-
(1–150)) fused to the His6 tag. This protein, termed PknG-Trx,
was purified and employed as a substrate in PknG kinase assays.
Fig. 6C shows robust phosphorylation of PknG-Trx by PknG.
Control PknG-Trx autophosphorylation experiments revealed
that PknG-Trx does not have the ability to phosphorylate itself
(data not shown). A comparison of the peptide maps of PknG
and PknG-Trx showed that the latter accounts for two of the
major phosphorylation sites in the PknG peptidemap (Fig. 6D).
Because phosphoamino acid analysis in Fig. 1D revealed that
PknG exclusively phosphorylates on threonine residue(s), we
individually mutagenized the 12 threonines present in PknG-
Trx to alanine. To identify the phosphosphorylation site(s) we
compared peptides of wild type PknG-Trx and the mutants.
With the exception of PknG-Trx-T63A, the patterns of tryptic
phosphopeptides of all the mutants were similar to that of
PknG-Trx (data not shown). Next, we mutagenized Thr-63 to
alanine in PknG, and compared the peptide map of this mutant
with those of PknG,which clearly revealed the loss of twomajor
phosphorylation spots present in PknG and PknG-Trx maps
(Fig. 6D). These results demonstrateThr-63 to be amajor phos-
phorylation site in the N-terminal region. Subsequently, we
assessed the role of Thr-63 inmodulating PknG kinase activity.
In vitro kinase assays carried out with purified PknG, PknG-
T63A, and PknG-(74–750) showed that activity of PknG-T63A
is similar to that of PknG (Fig. 7A). To further substantiate this
observation, kinase assays were carried out with PknG, PknG-
T63A, PknG-K181M, and PknG-T309A pulled down from the
lysates ofM. smegmatis expressing these proteins (Fig. 7B). As
expected PknG-K181M and PknG-T309A were inactive. Fur-
thermore, these results clearly demonstrate that PknG-T63A is
as active as the wild type protein. To authenticate the phospho-
rylation site in vivo, wild type PknG, PknG kinase-dead mutant
(K181M), and the PknG phosphorylation site mutant (T63A)
were expressed as His-tagged proteins in M. smegmatis and
metabolically labeled with [32P]orthophosphoric acid. As
expected, PknGwas phosphorylated in vivo (Fig. 7C, first lane).
Surprisingly, the kinase inactive mutant PknG-K181M also
showed phosphorylation, perhaps indicating a transphospho-
rylation of PknG by another kinase inM. smegmatis. The most
significant observation, however, is that we could not detect
phosphorylation of PknG-T63A, validating in vivo phosphoryl-
ation of Thr-63.
The N-terminal Region of PknG Mediates the Survival of
Mycobacteria in Host Macrophages—M. smegmatis, a non-
pathogenic saprophytic species of mycobacteria, does not
express PknG, and is readily transferred to lysosomes upon
FIGURE 5. PknG exhibits transphosphorylation. A, the PknG gene was
cloned intoNdeI-HindIII sites ofM. tuberculosis shuttle vector pVV16.M. smeg-
matis expressing pVV16-PknG was metabolically labeled and C-terminal His-
tagged PknG was pulled down as described under “Experimental Proce-
dures.” The sample was resolved on 10% SDS-PAGE and transferred onto
nitrocellulose membrane, and the radiolabeled bands were visualized by
phosphorimaging. The radiolabeled band corresponding to PknG is indi-
cated by an arrow. B, in vitro kinase assays were carried out with or without 1
pmol of MBP-PknG using either 1 or 5 pmol of PknG-K181M as substrate.
Reactions were resolved on 8% SDS-PAGE, transferred onto nitrocellulose
membrane, and subjected to autoradiography. Bands corresponding to His-
PknG-K181M and MBP-PknG are indicated.
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infection in macrophages (23, 37). Ectopic expression of PknG
in M. smegmatis renders it resistant to clearance by macro-
phages. Moreover, the kinase activity of PknG is important for
this phenomenon, as the expression
of a kinase-dead mutant of PknG
(PknG-K181M) does not confer this
resistance, and the bacteria con-
tinue to be actively transfered to
lysosomes (37). To address any pos-
sible role of the first 73 amino acids
of PknG, especially that of the thre-
onine 63 and Trx motifs, in the sur-
vival of mycobacteria in the host
macrophages, we transformed GFP
expressing M. smegmatis with
either plasmid vector alone, or plas-
mids harboring PknG, PknG-
K181M, PknG-(74–750), or PknG-
T63A or PknG-T1T2, and infected
macrophages with these trans-
formed bacteria. Three hours post-
infection, survival of M. smegmatis
transformants was assessed by the
co-localization of GFP with lyso-
tracker red. As expected, most of
the wild type M. smegmatis co-lo-
calized with the lysotracker red (Fig.
8). In agreement with the earlier
results, M. smegmatis expressing
PknG were able to survive outside
the lysosomal compartment, and
bacteria expressing PknG-K181M
showed lysosomal transfer compa-
rable with wild type M. smegmatis
(Fig. 8) (37). The results presented
here show that M. smegmatis
expressing PknG mutants PknG-
(74–750), PknG-T63A and PknG-
T1T2 showed increased lysosomal
transfer, implying reduced survival
compared with those expressing
PknG (Fig. 8). Thus, deleting the
first 73 amino acids or mutating
Thr-63 or the Trx motifs compro-
mised the ability of PknG to rescue
the clearance of M. smegmatis by
macrophages. These results demon-
strate a definitive role for the N-ter-
minal 73 amino acids of PknG, Trx
motifs, and the Thr-63 residue, the
only phosphorylation site detected
in vivo, in PknG-mediated pre-
vention of lysosomal transfer of
mycobacteria.
Ectopic Expression of PknG in M.
smegmatis Enhances Its Persistence
in Mouse Tissues—To probe the in
vivo significance of these important
observations we investigated the role of PknG and PknG
mutants in pathogenesis of mycobacteria in mice. Toward this,
M. smegmatis strains expressing pVV16 or PknG, or PknG
FIGURE 6. Threonine 63 is a major phosphorylation site in PknG. A, depicts the radioactive peaks eluted
from the C-18 column at different retention times. B, aliquots of each peak were resolved by two-dimensional
thin layer chromatography and thepeptidemapswere comparedwith that ofwild type PknG. Spotsmigrating
at the same positions in the peptide maps of wild type PknG and the individual peaks are numbered and
indicated. C, in vitro kinase assays were carried out with 1 pmol of PknG in a 40-l reaction with or without 5
pmol of PknG-Trx as the substrate. Reactions were resolved on 12% SDS-PAGE, transferred to nitrocellulose
membrane, and subjected to autoradiography. Bands corresponding to PknGandPknG-Trx are indicated.D, in
vitro phosphorylated PknG, PknG-Trx, and PknG-T63A were digested with trypsin, and the resulting phos-
phopeptides were mapped by two-dimensional resolution by thin layer chromatography. Missing phospho-
rylation sites in PknG-T63A are indicated by the dotted circles.
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mutants were injected intraperitoneally, and the bacterial load
in liver, lungs, and spleen were analyzed by counting the CFU.
Initial experiments revealed that very few bacteria localized to
the lung and liver andwere rapidly cleared by day 4 as compared
with the spleen. Hence, further analyses were restricted only to
spleen, and CFUs were determined 2, 5, and 10 days post-infec-
tion. On day 2 all the strains showed comparable CFUs signify-
ing similar bacterial load on the spleen (Fig. 9B). By day 5, the
spleen CFUs frommice infected withM. smegmatis expressing
PknG showed an overall decrease, although the numbers
remained significantly high as compared with the parent strain
(Fig. 9C). In the case of mice infected with M. smegmatis
expressing PknG-K181M (kinase dead) we noticed a significant
decrease in the spleenCFUs, however, the numberswere higher
than the control (Fig. 9C). Similar results were obtainedwithM.
smegmatis strains expressing PknG-(74–750), PknG-T63A,
and PknG-T1T2. By day 10, very fewCFUs could be detected in
the spleen of mice infected with the M. smegmatis strain har-
boring pVV16 vector or PknG-K181M, or PknG-(74–750) or
PknG-T1T2 mutants (Fig. 9D). Interestingly, 5-fold higher
CFUs were detected in the spleen of mice infected with theM.
smegmatis strain expressing PknG.CFUsobtained in the case of
mice infected withM. smegmatis expressing PknG-T63A were
2.5-fold higher than those observed for the control. However,
these numbers were 2-fold lower than those obtained with
PknG.
A comparison of spleen sizes on these different days
revealed a substantial splenomegaly (Fig. 9A) in mice
infected with M. smegmatis expressing PknG. The mice
infected with M. smegmatis expressing PknG mutants
showed spleen sizes comparable with mice infected with
wild type M. smegmatis (control) (Fig. 9A). By day 10 the
spleen size in mice infected with M. smegmatis expressing
PknG was twice the size compared with those infected with
the wild type strain or the strains expressing PknG-K181M,
PknG-(74–750), and PknG-T1T2 and this observation was
reinforced by the fact that the spleen had higher bacterial
load (Fig. 9D). We also observed slightly enlarged spleen in
mice infected with M. smegmatis expressing PknG-T63A,
which is in keeping with the spleen CFU count obtained on
day 10. Our results for the first time demonstrate that
expression of PknG in non-pathogenic mycobacteria allows
the continued existence of these bacteria in host tissue.
DISCUSSION
STPKs have been shown to be involved in key regulatory
functions in the organism (2, 20). This study reports the
biochemical characterization of PknG and the possible func-
tional roles of the different domains (and of specific amino
acid residues therein) in regulating kinase activity and PknG-
mediated virulence. PknG-mediated phosphorylation of uni-
versal (canonical) substrates such as Mbp and histone HIIA
fractions was poor compared with the other characterized
M. tuberculosis STPKs. We found that GarA, a homolog of
CgPknG substrate OdhI, is a robust substrate ofM. tubercu-
losis PknG, as GarA is phosphorylated with at least 10-fold
higher efficiency than the canonical substrates (Fig. 1).
O’Hare et al. (12) reported that PknG-mediated phosphoryl-
ation of GarA regulates glutamate metabolism in mycobac-
teria. This work is an attempt to understand the importance
of the N- and C-terminal domains that sandwich the kinase
domain of PknG, wherein GarA has been used as a substrate
for all biochemical analyses.
The C-terminal TPR domain, a helical coiled-coil struc-
ture, reported to be present in proteins involved in signaling
pathways (50) is known to play a role in arbitrating protein-
protein interactions (51). Results showed that deleting the
TPR domain decreased kinase activity by 80% (Table 1).
Although the N-terminal deletion mutants (see Fig. 2 and
Table 1; PknG-(151–750) and –(74–750)) showed a severely
compromised activity, we observed that these mutants could
bind ATP (supplemental Fig. S2), suggesting that the loss of
activity may be due to the lack of an essential regulatory
function. The Trx-fold, a structural motif consisting of a
four-stranded  sheet and three flanking  helices, has been
implicated in regulating various functions including iron/
cadmium binding, maintaining the protein in-folded state,
and in sensing the redox state of the environment (52).
Although the sequence similarity between various proteins
that contain this fold is minimal, they are present in most
redox proteins. The active site motif CXXC is conserved
FIGURE 7. Threonine 63 is the only phosphorylation site in vivo. A, in
vitro kinase assays were carried out as described using 1 pmol of PknG,
PknG-T63A, and PknG-(74–750) with or without 5 pmol of GarA and 100
M cold ATP, 10 Ci of [-32P]ATP. B, His-tagged PknG or PknG-K181M, or
PknG-T309A or PknG-T63Awere pulled down from lysates ofM. smegmatis
strains expressing the proteins, using nickel-affinity beads. The pulled
down proteins were used in in vitro kinase assays as described using 25
pmol of GarA and 100 M cold ATP, and 10 Ci of [-32P]ATP. C, M. smeg-
matis cells transformed with pVV16-PknG, pVV16-PknG-K181M, or pVV16-
PknG-T63A were metabolically labeled and the His-tagged PknG proteins
were pulled down as described under “Experimental Procedures.” After
resolution on 10% SDS-PAGE and transfer to nitrocellulose membrane the
radiolabeled bands were visualized by phosphorimaging. The radiola-
beled band corresponding to PknG is indicated by an arrow (upper panel).
To determine the expression levels, the membrane was probed with
PknG rabbit polyclonal antibodies (lower panel).
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across all these proteins (52). The Trx-fold in PknG was
suggested to be a characteristic ruberedoxin domain involved
in iron binding (32).We carried out an iron staining experiment
with purified PknG and PknG-T1T2 mutant, using ferritin as
the positive control as described (53). Althoughwe could detect
staining of ferritin, PknG and PknG-T1T2 did not show any
iron staining (data not shown), which suggested that the role of
the Trx-fold in PknG is not that of iron binding. Results shown
in Fig. 3 demonstrate that the PknG kinase activity is sensitive
to the redox environment, and mutating the conserved cys-
teines to alanines results in abrogation of this response. In con-
trast to a previous report (32), where simultaneous mutations
of these conserved cysteines to serines resulted in an inactive
kinase, we observed that the PknG-T1T2 mutant retained
40–50% activity (Fig. 3). This disparity in the results could be
due the fact that we mutated cys-
teine residues to alanine and not to
serine.
Serine/threonine kinases are
classified into two categories, RD
kinases and non-RD kinases,
depending on the presence or
absence of an arginine residue next
to the conserved aspartate residue
in the catalytic loop (54). RD kinases
are known to be phosphorylated on
their activation segment, which
includes the  helix, activation loop,
and the p  1 loop. Primary phos-
phorylation on the activation seg-
ment occurs in the activation loop
and in some cases secondary phos-
phorylation is known to occur in the
p 1 loop (55). Amongmycobacte-
rial kinases, phosphorylation in the
activation loop has been reported in
the case of PknA, -B, -E, -D, and -F.
In PknE, an additional phosphoryl-
ation has been detected on the thre-
onine residue in the p 1 loop (49,
56). The crystal structure of PknG
shows a stable activation loop, sug-
gesting the lack of phosphorylation
in the activation loop (32). The
phosphoamino acid analysis re-
vealed that PknG is exclusively
phosphorylated on threonine resi-
dues (Fig. 1D), but the activation
loop of PknG lacks threonine resi-
dues. Hence, we investigated the
possibility of the site of phosphoryl-
ation being threonine 309 in the p
1 loop of PknG. However, muta-
tional analysis clearly showed that
threonine 309 in PknG is not phos-
phorylated (Fig. 4). Interestingly,
our results show that the hydroxyl
group on threonine 309 is crucial for
PknG activity, suggesting a role in arbitrating interactions with
the substrate, or in stabilization of the activation segment.
We found PknG to phosphorylate the N-terminal Trx
domain (PknG-Trx) (Fig. 6) an observation that is in agreement
with previous findings (32). In vitro experiments revealed
Thr-63 to be the major phosphorylation site in the N-terminal
region (Fig. 6). With the help of mass spectrometry two groups
(12, 57) have determined, Thr-21, Thr-23, Thr-26, Thr-32,
Thr-63, Thr-64, and Ser-65 to be sites of phosphorylation in
PknG. In addition, they have found that PknG73 (which lacks
N-terminal 73 amino acids) is not phosphorylated, and suggest
that all phosphorylation sites lie within the N-terminal 73
amino acids. In contrast, we detected phosphorylation of
PknG-(74–750), i.e. PknG73 (Fig. 2), albeit at lower levels
compared with PknG, suggesting additional phosphorylation
FIGURE 8. The N-terminal region of PknG, threonine 63, and the Trx region mediate the survival of
mycobacteria in host macrophages. M. smegmatis expressing GFP was transformed with pVV16, pVV16-
PknG, pVV16-PknG-K181M, pVV16-PknG-(74–750), pVV16-PknG-T63A, or pVV16-PknG-T1T2. J774A.1 cells
plated on the coverslip were infected at an multiplicity of infection of 1:10 with GFP-M. smegmatis transfor-
mants, for 1 h. Three hours post-infection cells were stainedwith lysotracker red, fixed, andmounted.A, panels
in first column, GFP-M. smegmatis expressing variousmutants of PknG. Panels in second column, lysotracker red
staining to mark acidic compartments. Panels in third column, co-localization of M. smegmatis with the
lysosomal compartment of cell. The images shown are representative images taken 3 h post-infection
using a Carl Zeiss Axiovision LSM510 meta confocal microscope. B and C, graph depicting the percent of
GFP-M. smegmatis expressing PknG or PknG mutants that co-localize with lysotracker red. Images were
procured using a Carl Zeiss Imager M1 fluorescence microscope. Twenty-five fields were counted for each
sample and the percent co-localization was calculated as (GFP co-localized with lysotracker red/total
number of infected cells that were counted) 100. Values obtained from two independent experiments
were used for calculating the mean  S.E.
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sites elsewhere. This result is in agreement with an earlier
report that suggested phosphorylation of the C-terminal TPR
domain (35). Although PknG phosphorylates various residues
in the N-terminal region in vitro, metabolic labeling experi-
ments withM. smegmatis expressing various PknG constructs
have unambiguously revealed that Thr-63 is the only phospho-
rylation site in vivo (Fig. 7). Interestingly, we observed in vivo
phosphorylation of kinase-inactive PknG (PknG-K181M) as
well, suggesting phosphorylation of PknG by other serine/thre-
onine kinase(s).
The role of an active formof PknG in the continued existence
ofM. bovis BCG inmacrophages by evasion of lysosomal fusion
has been well documented (37, 57). Our study presents data
indicating the importance of the first 73 amino acids in PknG-
mediated evasion of the lysosomal transfer of mycobacteria.
These results are in agreement with a recent report where the
authors have obtained similar results by overexpressing the
PknG73 mutant inM. bovis BCG (57). Most importantly, our
results definitively demonstrate the essential role of threonine
63, the only in vivo phosphorylation site of PknG, inmodulating
the survival of themicrobe in its host. Thus phosphorylation on
Thr-63 is an importantmode of reg-
ulation of the PknGactivity. In addi-
tion, results also reveal a prominent
role for conserved cysteines in the
Trx motif. This motif also seems to
be essential for regulating PknG-
mediated survival of mycobacteria
(see Figs. 8 and 9), thus suggesting a
correlation between the role of the
Trx motifs present in sensing the
redox environment and PknG-me-
diated survival of mycobacteria.
Upon infecting mice with recom-
binant M. smegmatis we found that
the expression of PknG inM. smeg-
matis brings about a marked differ-
ence in pathogenicity and its sur-
vival within the host. A significantly
enlarged spleen and higher CFUs in
mice infected with the M. smegma-
tis strain expressing PknG, as com-
pared with the wild type M. smeg-
matis, points toward a stronger
inflammatory response against the
pathogen in the host, and a role for
PknG in the persistence of the path-
ogenic mycobacteria in host tissues
after an initial inflammatory re-
sponse. The fact that none of the
mutants could survive in mice
spleen as effectively as strains ex-
pressing PknG underlines the
importance of these residues in
PknGmediating its effect. Thus, the
N-terminal 73-amino acid region of
PknG, the conserved Trx motifs of
PknG, and the phosphorylation on
Thr-63 are independently essential for in vitro and in vivo func-
tioning of PknG. Future investigations will be aimed at under-
standing the PknG signaling cascade and determine the role
played by other STPKs in modulating PknG-mediated survival
of mycobacteria in the host.
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